Cellex Incorporated Email Format
Medical Equipment ManufacturingNorth Carolina, United States11-50 Employees
Cellex Incorporated is a biotechnology company focused on developing technologies, instruments and assays for diagnosing human diseases, with an emphasis on point-of-care testing. Founded in 2002, the company is based in North Carolina, with corporate headquarters in the Research Triangle Park area and manufacturing facilities in China, and an operation in Durham. Its products aim to provide rapid diagnostics usable outside traditional laboratories for a range of medical conditions. On April 1, 2020, Cellex became the first company to receive FDA Emergency Use Authorization for a COVID-19 serology test (qSARS-CoV-2 IgG/IgM Rapid Test). In October 2020, the company announced an expansion of its European manufacturing footprint with a cell manufacturing plant in Cologne, Western Europe, to produce advanced therapy medicinal products for cryopreservation and cell purification.